179 related articles for article (PubMed ID: 7687721)
41. The diverse effects of cromakalim on tension and 86Rb efflux in canine arterial smooth muscle.
Masuzawa K; Matsuda T; Asano M
Br J Pharmacol; 1991 May; 103(1):1033-40. PubMed ID: 1878743
[TBL] [Abstract][Full Text] [Related]
42. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
[TBL] [Abstract][Full Text] [Related]
43. Comparison of cromakalim-induced relaxation of potassium precontracted rabbit, cat, and rat isolated cerebral arteries.
Parsons AA; Ksoll E; Mackert JR; Schilling L; Wahl M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):384-92. PubMed ID: 1906583
[TBL] [Abstract][Full Text] [Related]
44. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
Wilson C
J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
[TBL] [Abstract][Full Text] [Related]
45. Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.
Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
Eur J Pharmacol; 1988 Oct; 155(3):229-37. PubMed ID: 3234486
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of arterial 42K efflux by ATP depletion and cromakalim is antagonized by glyburide.
Post JM; Jones AW
Am J Physiol; 1991 Mar; 260(3 Pt 2):H848-54. PubMed ID: 1900392
[TBL] [Abstract][Full Text] [Related]
47. Effect of cromakalim on KCl-, noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery.
Savineau JP; Marthan R
Pulm Pharmacol; 1993 Mar; 6(1):41-8. PubMed ID: 8477154
[TBL] [Abstract][Full Text] [Related]
48. The relationship of KCl- and prostaglandin F2 alpha-mediated increases in tension of the porcine coronary artery with changes in intracellular Ca2+ measured with fura-2.
Balwierczak JL
Br J Pharmacol; 1991 Oct; 104(2):373-8. PubMed ID: 1797304
[TBL] [Abstract][Full Text] [Related]
49. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of inhibitory effects of CD-349 and K(+)-channel activators on noradrenaline-induced contraction and changes in levels of cyclic GMP in rat aorta.
Miyata N; Tsuchida K; Kaneko K; Tanaka M; Otomo S
Gen Pharmacol; 1990; 21(5):665-9. PubMed ID: 2177435
[TBL] [Abstract][Full Text] [Related]
51. Multiple mechanisms in the smooth muscle relaxant action of calcitonin gene-related peptide (CGRP) in the guinea-pig ureter.
Maggi CA; Giuliani S; Santicioli P
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):537-47. PubMed ID: 7870193
[TBL] [Abstract][Full Text] [Related]
52. Hyperpolarizing action of cromakalim on the rat aorta.
Doggrell SA; Smith JW; Downing OA; qilson KA
Eur J Pharmacol; 1989 Dec; 174(1):131-3. PubMed ID: 2612577
[TBL] [Abstract][Full Text] [Related]
53. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
Triggle CR; Li YQ; Wyse DG
Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
[No Abstract] [Full Text] [Related]
54. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
55. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
[TBL] [Abstract][Full Text] [Related]
56. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
Cook NS; Weir SW; Danzeisen MC
Br J Pharmacol; 1988 Nov; 95(3):741-52. PubMed ID: 2974739
[TBL] [Abstract][Full Text] [Related]
57. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
58. An approach to differentiate between noradrenaline-elicited contractile processes in the rat isolated aorta.
Koch P; Wilffert B; Wilhelm D; Peters T
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):454-61. PubMed ID: 2255337
[TBL] [Abstract][Full Text] [Related]
59. Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea-pig isolated renal pelvis and ureter.
Maggi CA; Giuliani S; Santicioli P
Br J Pharmacol; 1994 Mar; 111(3):687-94. PubMed ID: 8019747
[TBL] [Abstract][Full Text] [Related]
60. Potassium channel openers relax A23187-induced nifedipine-resistant contraction of rat aorta.
Yamashita T; Masuda Y; Tanaka S
J Cardiovasc Pharmacol; 1994 Dec; 24(6):914-20. PubMed ID: 7898074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
